Renaissance Technologies - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$12,619
+30.2%
138,513
-26.1%
0.02%
+38.5%
Q4 2022$9,691
-100.0%
187,413
-45.7%
0.01%
-60.6%
Q3 2022$23,571,000
+1745.8%
345,113
+1607.6%
0.03%
+1550.0%
Q2 2021$1,277,000
-92.0%
20,211
-94.6%
0.00%
-90.0%
Q1 2021$16,027,000
+29.5%
373,513
+72.7%
0.02%
+53.8%
Q4 2020$12,373,000
+1972.5%
216,313
+1008.6%
0.01%
Q4 2019$597,000
+16.8%
19,513
-25.5%
0.00%
Q1 2019$511,00026,2000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders